COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 334.2 | 5 | 0045-0550 | 220.89 | 550.54 | 202 | 57.94 | 0.756 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 425.7 | 5 | 0046-0548 | 249.45 | 548.43 | 172 | 52.28 | 0.791 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 649.9 | 5 | 0047-0563 | 153.70 | 562.95 | 110 | 53.36 | 0.486 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 394.2 | 5 | 0048-0583 | 634.62 | 583.75 | 264 | 63.84 | 0.814 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 486.1 | 5 | 0049-0594 | 129.69 | 594.89 | 191 | 54.18 | 0.818 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 395.0 | 5 | 0050-0606 | 526.68 | 606.72 | 254 | 62.53 | 0.816 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 400.8 | 5 | 0051-0621 | 548.39 | 620.38 | 261 | 60.53 | 0.895 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 616.9 | 5 | 0052-0633 | 394.79 | 633.43 | 175 | 57.94 | 0.655 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 329.7 | 5 | 0053-0649 | 879.38 | 648.46 | 267 | 62.77 | 0.852 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 469.3 | 5 | 0054-0658 | 86.40 | 658.34 | 208 | 66.04 | 0.599 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 458.3 | 5 | 0055-0659 | 146.43 | 658.61 | 215 | 57.11 | 0.828 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 415.5 | 5 | 0056-0676 | 660.44 | 675.54 | 242 | 63.36 | 0.758 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 685.2 | 5 | 0057-0680 | 392.72 | 679.46 | 237 | 61.94 | 0.776 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 664.8 | 5 | 0058-0686 | 413.76 | 685.86 | 186 | 51.70 | 0.875 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 613.6 | 5 | 0059-0701 | 377.39 | 701.40 | 197 | 55.70 | 0.798 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 737.4 | 5 | 0060-0703 | 482.30 | 702.70 | 182 | 64.67 | 0.547 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 685.4 | 6 | 0001-0056 | 930.28 | 56.78 | 245 | 59.11 | 0.881 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 429.7 | 6 | 0002-0062 | 146.01 | 62.35 | 215 | 56.77 | 0.838 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 397.0 | 6 | 0003-0073 | 880.87 | 72.50 | 278 | 64.43 | 0.842 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 701.7 | 6 | 0004-0082 | 78.92 | 81.60 | 182 | 51.94 | 0.848 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 395.1 | 6 | 0005-0093 | 752.88 | 94.14 | 288 | 67.01 | 0.806 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 485.4 | 6 | 0006-0112 | 641.80 | 112.21 | 197 | 57.60 | 0.746 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 992.1 | 6 | 0007-0120 | 317.19 | 120.41 | 213 | 53.11 | 0.949 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 483.4 | 6 | 0008-0124 | 828.85 | 124.44 | 232 | 71.98 | 0.563 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 429.7 | 6 | 0009-0133 | 761.87 | 133.64 | 241 | 61.01 | 0.814 |